Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Surgical Wound Infection 2Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Esophagitis, Peptic 1Carcinoma, Hepatocellular 1Barrett Esophagus 1Bacterial Infections 1Adenocarcinoma Of Esophagus 1

Interventions

Endoscopy 13Endoscopy, Digestive System 12Radiofrequency Ablation 7Esomeprazole 7Biopsy 7Endoscopic Mucosal Resection 6Specimen Handling 4Proflavine 4Omeprazole 4Aspirin 4Gastroscopy 3YF 476 2Proton Pump Inhibitors 2Photochemotherapy 2Narrow Band Imaging 2Microscopy, Confocal 2Metformin 2Lansoprazole 2Itraconazole 2Endoscopes 2Diagnostic Imaging 2Dexlansoprazole 2Cryotherapy 2Cryosurgery 2Breath Tests 22-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 2rofecoxib 1polyphenon E 1plecanatide 1omeprazole, sodium bicarbonate drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Barrett Esophagus × chlorhexidine gluconate × Clear all
NCT02513784 2022-09-22

Mouthwash

Columbia University

Phase NA Completed
20 enrolled 11 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus, Esophagitis, Peptic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡